Nothing here asks for your name. One label, two mechanisms: platelets add no volume; hyaluronic acid gel occupies space the same day. None of these uses is FDA-approved, and the two behave differently enough that the choice starts there.
Book a consultationAsk us privately
Intimate wellness is non-surgical genital treatment by a provider in a private room: platelet-rich plasma injections, or hyaluronic acid filler in the labia majora. Reassessed at 8 to 12 weeks. None of these uses is FDA-approved, and the two behave differently enough that the choice starts there.
You do not need the right word. Platelet treatments inject your own concentrated platelets, adding no volume. Hyaluronic acid gel occupies space the same day.
One of these can be undone. The other cannot. Platelet-rich plasma is your own platelets, drawn and spun on site; it stays until your body clears it. Hyaluronidase dissolves hyaluronic acid filler. Energy-based devices are different again. In 2018 the FDA issued a safety communication stating that these devices are neither approved nor cleared for vaginal rejuvenation.


| Option | What is placed | What it addresses | Regulatory status | Typical course | Onset and duration | Reversible |
|---|---|---|---|---|---|---|
| Platelet injection, female | Platelet-rich plasma from your own blood | Discussed for sensation, arousal and dryness, and for mild stress urinary leaking. Not FDA-approved for any of them; the published evidence is small and mixed | Not FDA-approved for this use | Usually one session, reassessed at 8 to 12 weeks | Nothing immediate; change reported between week 4 and week 12 | No. Resolves on its own |
| Vaginal rejuvenation | Platelet injection here, or a referral for prescription therapy | Dryness, burning, discomfort with sex, laxity complaints | Umbrella marketing term. No energy device is FDA-cleared for it | One platelet session here, or an ongoing prescription elsewhere | Weeks for platelets; prescription therapy is assessed at 8 to 12 weeks | Prescription therapy is stopped; a platelet injection is not reversible |
| Labia puff | Hyaluronic acid filler in the labia majora | Volume loss and deflation of the outer labia | Off-label use of an approved filler | One session, most patients 2 to 4 mL | Visible same day, settles by week 2 to 4; roughly 6 to 12 months | Yes. Dissolved with hyaluronidase |
| No treatment, or referral | Nothing | Pain, bleeding, a lump, urinary symptoms, suspected hormonal or vascular cause | Standard medical care | Referral to gynecology, urology, or pelvic floor physical therapy | Not applicable | Not applicable |
A way of sorting, not a ranking. What decides: volume and shape, or sensation and tissue quality. Ranges reflect product labeling and practice observation, not a promise of result. No injectable option here is FDA-approved for the use described; the prescription therapies named are approved for genitourinary syndrome of menopause, and vaginal estrogen and ospemifene carry FDA boxed warnings.
Autologous platelet-rich plasma — Prepared from 20 to 60 mL of your own blood, drawn the same day and used within the hour. Adds no volume.
Platelet-rich fibrin (PRF) — Spun without anticoagulant, so platelets sit in a fibrin matrix and release more slowly. No preparation system is FDA-cleared for genital use.
Juvéderm® Voluma® XC — Off-label placement of a filler approved for the face. Chosen for a cohesive gel that holds its shape.
Restylane® Lyft — A larger-particle gel that handles differently in tissue, which is what the choice between the two turns on. Also an off-label placement.
Ask about follow-up timing, contact arrangements, and any additional charges before treatment.
Prescription therapy for genitourinary syndrome of menopause — Vaginal estrogen and prasterone, both vaginal inserts, or ospemifene, an oral tablet that acts on estrogen receptors. These carry more controlled evidence than any injectable in this category, and are often the starting point. Vaginal estrogen carries the FDA boxed warning for estrogen products, covering endometrial cancer, cardiovascular disorders, breast cancer and probable dementia, and ospemifene carries a boxed warning for endometrial cancer and cardiovascular disorders; prasterone carries none. A prescriber reviews these against your history before anything is written.
A private conversation, and an examination where relevant. History, medications and what you tried come first.
Sensation and tissue quality point one way. Volume and shape the other. Not substitutes.
Topical anesthetic 20 to 30 minutes, then local, then the injection. 30 to 60 minutes, chaperone offered.
Filler is reviewed at two weeks, platelets at 8 to 12. Both booked at treatment.

A first visit is conversation: history, medications, what you tried. The room is private, opening onto a hallway. About 90 minutes, mostly talking.
Longer than feels natural. Filler shows the same day; swelling settles over 2 to 4 weeks, volume holds 6 to 12 months. Platelets show nothing immediately.


No. The two reasons differ. No dermal filler is FDA-approved for genital augmentation, so labia filler is an off-label use of an approved product: the FDA reviewed the product for a different use, which is legal and common in medicine. Platelet-rich plasma sits differently. No platelet preparation carries an approved label for any use here, so there is no approved use for it to sit outside of, and it is described as an unapproved preparation rather than as off-label. Which applies is named before you consent.
Most describe pressure, not sharp pain. Topical anesthetic sits 20 to 30 minutes, then buffered lidocaine. Soreness for a day is common. Sharp pain is not expected; say so.
No. Appointment reminders, invoices and card statements read Rouge Aesthetics and name no treatment. Scheduling does not ask for a reason. No photographs are taken, and no anatomical imagery appears on this site. You never have to ask.
The cost depends on your treatment plan. Call (614) 425-1633 for current pricing and ask what consultation, treatment, and follow-up charges apply.
Yes, and you never have to ask. A chaperone is offered at every visit, and the offer is documented whether you accept or decline. Bring your own support person instead, or have nobody present at all.
Wait two weeks after filler in the labia majora: friction can move a gel that has not settled. After a platelet injection the interval is 48 hours. You leave with the figure in writing.
Yes. Hyaluronic acid filler can be dissolved with hyaluronidase, usually in a single appointment, and hyaluronidase is kept on site. Platelet-rich plasma cannot be reversed — it is a concentrate of your own blood that the body clears over months. That difference is worth weighing.
Not reliably. Small studies report improvement in mild stress urinary incontinence after platelet-rich plasma, but most are uncontrolled and short. Moderate or severe leaking, urgency or prolapse belongs with a urogynecologist and pelvic floor therapy.
That happens often, and is not a wasted visit. You leave with the reason in writing, and any appropriate referral. Ask about consultation fees when booking. Usually the complaint points to a gynecologic, urologic or hormonal cause an injection cannot reach.
No platelet-rich plasma protocol is FDA-approved for genital treatment, and no dermal filler is FDA-approved for genital augmentation. Every injectable treatment described on this page is either an off-label use of an approved product or a use the FDA has not reviewed. The prescription therapies named for genitourinary syndrome of menopause are FDA-approved for that indication, and two of them, vaginal estrogen and ospemifene, carry FDA boxed warnings that the prescriber reviews with you. Off-label use is legal and common in medicine, and we state which applies before you consent.
No energy-based device is cleared or approved by the U.S. Food and Drug Administration for vaginal rejuvenation, and the FDA issued a safety communication on that marketing in 2018. Rouge Aesthetics owns no such device and does not refer for one.
Individual results vary. Nothing on this page is a promise of a change in sensation, function, size, or a partner's experience, and nothing described here resolves an underlying medical condition.
Treatment requires an in-person consultation and a medical eligibility review. Pain, bleeding, a new lump, urinary symptoms, or suspected hormonal or vascular causes are referred to a gynecologist, urologist, or pelvic floor physical therapist before any injection is considered.
Rouge Aesthetics · 101 Mill Street, Suite 210, Gahanna, OH 43230 · (614) 425-1633
Individual results vary. This website provides general information and does not replace an individual consultation.